See more : Kesselrun Resources Ltd. (KES.V) Income Statement Analysis – Financial Results
Complete financial analysis of ToolGen Incorporated (199800.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ToolGen Incorporated, a leading company in the industry within the sector.
- Triton International Limited (TRTN) Income Statement Analysis – Financial Results
- Personas Social Incorporated (PRSNF) Income Statement Analysis – Financial Results
- Arabian Centres Company (4321.SR) Income Statement Analysis – Financial Results
- SEPC Limited (SEPC.NS) Income Statement Analysis – Financial Results
- Capital Power Corporation (CPX.TO) Income Statement Analysis – Financial Results
ToolGen Incorporated (199800.KQ)
Website: https://www.toolgen.com
About ToolGen Incorporated
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.10B | 743.46M | 1.60B | 713.09M | 0.00 |
| Cost of Revenue | 168.45M | 185.06M | 510.87M | 351.52M | 0.00 |
| Gross Profit | 934.96M | 558.40M | 1.09B | 361.58M | 0.00 |
| Gross Profit Ratio | 84.73% | 75.11% | 68.02% | 50.71% | 0.00% |
| Research & Development | 6.75B | 6.30B | 5.45B | 4.15B | 0.00 |
| General & Administrative | 504.67M | 257.23M | 158.17M | 173.95M | 0.00 |
| Selling & Marketing | 4.56B | 5.98B | 8.33B | 3.97B | 0.00 |
| SG&A | 5.06B | 6.24B | 8.48B | 4.14B | 0.00 |
| Other Expenses | 6.21B | 15.82M | 40.62M | 2.55M | 0.00 |
| Operating Expenses | 18.02B | 19.94B | 21.81B | 15.33B | 0.00 |
| Cost & Expenses | 18.19B | 20.13B | 22.32B | 15.68B | 0.00 |
| Interest Income | 2.07B | 1.23B | 195.79M | 197.81M | 549.30M |
| Interest Expense | 428.24M | 28.38M | 29.25M | 32.19M | 11.06M |
| Depreciation & Amortization | 1.54B | 1.08B | 874.67M | 792.77M | 0.00 |
| EBITDA | -40.37B | -18.31B | -19.79B | -14.06B | -14.06B |
| EBITDA Ratio | -3,658.68% | -2,296.48% | -1,238.32% | -1,970.79% | 0.00% |
| Operating Income | -17.09B | -19.39B | -20.73B | -14.97B | 0.00 |
| Operating Income Ratio | -1,548.61% | -2,607.47% | -1,297.88% | -2,098.70% | 0.00% |
| Total Other Income/Expenses | -25.25B | 1.21B | 38.22M | 83.77M | 353.21M |
| Income Before Tax | -42.34B | -18.18B | -20.69B | -14.88B | 0.00 |
| Income Before Tax Ratio | -3,837.21% | -2,444.93% | -1,295.49% | -2,086.95% | 0.00% |
| Income Tax Expense | 0.00 | 1.24B | 76.61M | 119.35M | 53.90M |
| Net Income | -42.34B | -18.18B | -20.69B | -14.88B | 0.00 |
| Net Income Ratio | -3,837.21% | -2,444.93% | -1,295.49% | -2,086.95% | 0.00% |
| EPS | -5.35K | -2.31K | -3.02K | -2.27K | -2.44K |
| EPS Diluted | -5.35K | -2.31K | -3.02K | -2.27K | -2.44K |
| Weighted Avg Shares Out | 7.91M | 7.86M | 6.86M | 6.56M | 6.48M |
| Weighted Avg Shares Out (Dil) | 7.91M | 7.86M | 6.86M | 6.56M | 6.48M |
Source: https://incomestatements.info
Category: Stock Reports